Skip to main content Accessibility help
×
Home

Implementation of the Targeted Assessment for Prevention Strategy in a healthcare system to reduce Clostridioides difficile infection rates

  • Katelyn A. White (a1), Minn M. Soe (a1), Amy Osborn (a2), Christie Walling (a3), Lucy V. Fike (a1), Carolyn V. Gould (a1), David T. Kuhar (a1), Jonathan R. Edwards (a1) and Ronda L. Cochran (a1)...

Abstract

Background:

Prevention of Clostridioides difficile infection (CDI) is a national priority and may be facilitated by deployment of the Targeted Assessment for Prevention (TAP) Strategy, a quality improvement framework providing a focused approach to infection prevention. This article describes the process and outcomes of TAP Strategy implementation for CDI prevention in a healthcare system.

Methods:

Hospital A was identified based on CDI surveillance data indicating an excess burden of infections above the national goal; hospitals B and C participated as part of systemwide deployment. TAP facility assessments were administered to staff to identify infection control gaps and inform CDI prevention interventions. Retrospective analysis was performed using negative-binomial, interrupted time series (ITS) regression to assess overall effect of targeted CDI prevention efforts. Analysis included hospital-onset, laboratory-identified C. difficile event data for 18 months before and after implementation of the TAP facility assessments.

Results:

The systemwide monthly CDI rate significantly decreased at the intervention (β2, −44%; P = .017), and the postintervention CDI rate trend showed a sustained decrease (β1 + β3; −12% per month; P = .008). At an individual hospital level, the CDI rate trend significantly decreased in the postintervention period at hospital A only (β1 + β3, −26% per month; P = .003).

Conclusions:

This project demonstrates TAP Strategy implementation in a healthcare system, yielding significant decrease in the laboratory-identified C. difficile rate trend in the postintervention period at the system level and in hospital A. This project highlights the potential benefit of directing prevention efforts to facilities with the highest burden of excess infections to more efficiently reduce CDI rates.

Copyright

Corresponding author

Author for correspondence: Katelyn A. White, E-mail: wwg6@cdc.gov

Footnotes

Hide All
a

Contributing members of the St Vincent’s CDI Task Force who led the prevention efforts described and continue to work on the CDI reduction initiative include Kenneth Rothfield MD, Frances Valencia-Shelton PhD, Florian Daragjati PharmD, Amy Svensson RN, Dorothy Salvatore RN, Bonnie Viergutz RN, Melodee Miller RN, Ronald Owen RN, Irene Pappalardo RN, Casey Higginbotham RN, Larita Knight RN, Laurie Mai RN, June Oliverson RN, and Christie Walling RN.

Footnotes

References

Hide All
1.Lessa, F, Mu, Y, Bamberg, W, et al.Burden of Clostridium difficile infection in the United States. N Engl J Med 2015;372:825834.
2.Magill, S, O’Leary, E, Janelle, S, et al.Changes in prevalence of healthcare-associated infections in US hospitals. N Engl J Med 2018;379:17321744.
3.National Targets and Metrics. Office of Disease Prevention and Health Promotion website. https://health.gov/hcq/prevent-hai-measures.asp. Published 2016. Accessed March 5, 2019.
4.The Targeted Assessment for Prevention (TAP) Strategy. Centers for Disease Control and Prevention website. https://www.cdc.gov/hai/prevent/tap.html. Published 2015. Accessed March 8, 2019.
5.What We Do. Health Services Advisory Group (HSAG) website. https://www.hsag.com/en/about/what-we-do-services/. Published 2014. Accessed March 5, 2019.
6.Soe, M, Gould, C, Pollock, D, Edwards, J.Targeted assessment for prevention of healthcare-associated infections: a new prioritization metric. Infect Control Hosp Epidemiol 2015;36:13791384.
7.St. Vincent’s Healthcare. Ascension website. https://www.jaxhealth.com/. Published 2007. Accessed March 5, 2019.
8.Wagner, AK, Soumerai, SB, Zhang, F, Ross-Degnan, D.Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002;27:299309.
9.Gebski, V, Ellingson, K, Edwards, J, Jernigan, J, Kleinbaum, D.Modelling interrupted time series to evaluate prevention and control of infection in healthcare. Epidemiol Infect 2012;140:21312141.
10.Multidrug-resistant organism and Clostridioides difficile infection (MDRO/CDI) module. Centers for Disease Control and Prevention website. http://www.cdc.gov/nhsn/PDFs/pscManual/12pscMDRO_CDADcurrent.pdf. Published 2019. Accessed March 17, 2019.
11.SAS/STAT 9.2 User’s Guide, second edition. COVTEST Statement. SAS website. https://support.sas.com/documentation/cdl/en/statug/63033/HTML/default/viewer.htm#statug_glimmix_sect001.htm. Published 2009. Accessed March 17, 2019.

Keywords

Implementation of the Targeted Assessment for Prevention Strategy in a healthcare system to reduce Clostridioides difficile infection rates

  • Katelyn A. White (a1), Minn M. Soe (a1), Amy Osborn (a2), Christie Walling (a3), Lucy V. Fike (a1), Carolyn V. Gould (a1), David T. Kuhar (a1), Jonathan R. Edwards (a1) and Ronda L. Cochran (a1)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed